| abstract |
The racemic forms of the 4- (4-Cyano-2-methoxyphenyl) -5-ethoxy-2-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide [(-) - enantiomer and (+) - enantiomer], 4- (4-Cyano-2-methoxyphenyl) -5-ethoxy-2,7-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide [(-) - enantiomer and (+) - enantiomer], 4- (4-Cyano-2-methoxyphenyl) -5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide [(+) - enantiomer], their racemic mixtures, the processes for the preparation of amides, their uses for the treatment and / or prophylaxis of diseases, especially cardiovascular disorders; and the pharmaceutical compositions containing them for this purpose. |